首页> 美国卫生研究院文献>Blood Transfusion >A calcium-containing electrolyte-balanced hydroxyethyl starch (HES) solution is associated with higher factor VIII activity than is a non-balanced HES solution but does not affect von Willebrand factor function or thromboelastometric measurements - results of a model of in vitro haemodilution
【2h】

A calcium-containing electrolyte-balanced hydroxyethyl starch (HES) solution is associated with higher factor VIII activity than is a non-balanced HES solution but does not affect von Willebrand factor function or thromboelastometric measurements - results of a model of in vitro haemodilution

机译:含钙的电解质平衡羟乙基淀粉(HES)溶液比非平衡的HES溶液具有更高的VIII因子活性但不影响von Willebrand因子功能或血栓弹力法测量-体外血液稀释模型的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHydroxyethyl starch (HES) is known to impair blood coagulation. The impact of calcium-containing, balanced carrier solutions of HES on coagulation is controversial. We investigated the effects of increasing degrees of haemodilution with modern 6%, electrolyte-balanced HES vs non-balanced HES on coagulation in vitro, and compared the balanced HES to a balanced crystalloid solution for an internal control.
机译:背景技术羟乙基淀粉(HES)会损害血液凝结。含钙的HES平衡载体溶液对凝血的影响是有争议的。我们研究了用现代6%电解质平衡的HES与不平衡的HES进行血液稀释的程度提高对体外凝血的影响,并将平衡的HES与平衡的晶体溶液进行了内部比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号